Mitral insufficiency and pulmonary hypertension accompanying patent ductus arteriosus; report of three cases.

L. Linde,F. Adams

DOI: https://doi.org/10.1016/0002-9149(59)90415-1

1959-06-01

Abstract:

What problem does this paper attempt to address?

Low frequency variants associated with leukocyte telomere length in the Singapore Chinese population

Xuling Chang,Resham L. Gurung,Ling Wang,Aizhen Jin,Zheng Li,Renwei Wang,Kenneth B. Beckman,Jennifer Adams-Haduch,Wee Yang Meah,Kar Seng Sim,Weng Khong Lim,Sonia Davila,Patrick Tan,Jing Xian Teo,Khung Keong Yeo,Yiamunaa M.,Sylvia Liu,Su Chi Lim,Jianjun Liu,Rob M. van Dam,Yechiel Friedlander,Woon-Puay Koh,Jian-Min Yuan,Chiea Chuen Khor,Chew-Kiat Heng,Rajkumar Dorajoo

DOI: https://doi.org/10.1038/s42003-021-02056-7

IF: 6.548

2021-05-03

Communications Biology

Abstract:Abstract The role of low frequency variants associated with telomere length homeostasis in chronic diseases and mortalities is relatively understudied in the East-Asian population. Here we evaluated low frequency variants, including 1,915,154 Asian specific variants, for leukocyte telomere length (LTL) associations among 25,533 Singapore Chinese samples. Three East Asian specific variants in/near POT1 , TERF1 and STN1 genes are associated with LTL (Meta-analysis P 2.49×10 −14 –6.94×10 −10 ). Rs79314063, a missense variant (p.Asp410His) at POT1 , shows effect 5.3 fold higher and independent of a previous common index SNP. TERF1 (rs79617270) and STN1 (rs139620151) are linked to LTL-associated common index SNPs at these loci. Rs79617270 is associated with cancer mortality [HR 95%CI = 1.544 (1.173, 2.032), P Adj = 0.018] and 4.76% of the association between the rs79617270 and colon cancer is mediated through LTL. Overall, genetically determined LTL is particularly associated with lung adenocarcinoma [HR 95%CI = 1.123 (1.051, 1.201), P adj = 0.007]. Ethnicity-specific low frequency variants may affect LTL homeostasis and associate with certain cancers.

biology
Clinical Impact of Telomere Length Testing for Interstitial Lung Disease

David Zhang,Christina M Eckhardt,Claire McGroder,Shannon Benesh,Julie Porcelli,Christopher Depender,Kelsie Bogyo,Joseph Westrich,Amanda Thomas-Wilson,Vaidehi Jobanputra,Christine K Garcia

DOI: https://doi.org/10.1016/j.chest.2024.06.006

IF: 9.6

2024-06-29

Chest

Abstract:Background: Shortened telomere length (TL) is a genomic risk factor for fibrotic interstitial lung disease (ILD), but its role in clinical management is unknown. Research question: What is the clinical impact of TL testing on the management of ILD? Study design and methods: Patients were evaluated in the Columbia University ILD clinic and underwent Clinical Laboratory Improvement Amendments-certified TL testing by flow cytometry and fluorescence in situ hybridization (FlowFISH) as part of clinical treatment. Short TL was defined as below the 10th age-adjusted percentile for either granulocytes or lymphocytes by FlowFISH. Patients were offered genetic counseling and testing if they had short TL or a family history of ILD. FlowFISH TL was compared with research quantitative polymerase chain reaction (qPCR) TL measurement. Results: A total of 108 patients underwent TL testing, including those with clinical features of short telomere syndrome such as familial pulmonary fibrosis (50%) or extrapulmonary manifestations in the patient (25%) or a relative (41%). The overall prevalence of short TL was 46% and was similar across clinical ILD diagnoses. The number of short telomere clinical features was independently associated with detecting short TL (OR, 2.00; 95% CI, 1.27-3.32). TL testing led to clinical treatment changes for 35 patients (32%), most commonly resulting in reduction or avoidance of immunosuppression. Of the patients who underwent genetic testing (n = 34), a positive or candidate diagnostic finding in telomere-related genes was identified in 10 patients (29%). Inclusion of TL testing below the 1st percentile helped reclassify eight of nine variants of uncertain significance into actionable findings. The qPCR test correlated with FlowFISH, but age-adjusted percentile cutoffs may not be equivalent between the two assays. Interpretation: Incorporating TL testing in ILD impacted clinical management and led to the discovery of new actionable genetic variants.
Recent intellectual property law changes and their impact on drug discovery.

W. Kinney

Current Topics in Medicinal Chemistry

Abstract:
Abstract 3461: Shorter leukocyte telomere length and higher risk of primary liver cancer in a prospective cohort study

Sindhu Karnam,Kathryn Demanelis,Kenneth B. Beckman,Renwei Wang,Jennifer Adams-Haduch,Woon-Puay Koh,Jian-Min Yuan

DOI: https://doi.org/10.1158/1538-7445.am2024-3461

IF: 11.2

2024-03-22

Cancer Research

Abstract:Abstract Background: Telomeres are conserved tandem repeats at chromosome ends that are vital to maintaining chromosomal stability and preventing degradation. Shorter telomere lengths (TL) are typically associated with older biological age or poor health status and can activate programmed cell death, whereas longer telomere lengths can be indicative of younger age or abnormal replication processes with oncogenic mutations. Previous research has identified a link between telomere length and carcinogenesis, but relatively few studies have investigated TL and primary liver cancer (PLC) risk despite it being one of the leading causes of cancer worldwide. The goal of this analysis was to study this association in a large prospective cohort. Methods: Data was extracted from the Singapore Chinese Cohort Health Study, a cohort of 63,257 men and women aged 45-74 years at enrollment during 1993-1998. Telomere length was measured in peripheral leukocytes of 26,540 participants who provided baseline blood samples, using a validated quantitative polymerase chain reaction (qPCR) method. PLC incidence and death among cohort participants was annually surveilled using the nationwide Singapore Cancer Registry and the National Birth and Death Registry from study enrollment to 2015. For statistical analysis, a t test was performed to examine the differences in TL between participants who developed incident PLC and those who remained free of PLC. Cox proportional hazard method was used to estimate the hazard ratios (HRs) and their 95% confidence interval (CI) of PLC incidence according to TL quartiles. Results: Over a 12-year follow-up, 199 participants developed incident PLC. The relative TL was significantly lower in participants with incident PLC than those without (-6.7%, p < 0.001). Multivariate Cox regression model showed an inverse association between TL quartile and risk of PLC (p for trend = 0.009). Compared with the lowest quartile, HRs (95% CIs) of PLC for the 2nd, 3rd, and highest quartile of TL were 0.78 (0.54-1.12), 0.75 (0.51-1.11), and 0.57 (0.37-0.88), respectively, after adjustment for age, sex, alcohol use, body mass index, and smoking status. Conclusion: The present analysis demonstrated a statistically significant association between shorter telomere length and increased risk of PLC in a large prospective cohort of Singaporean Chinese. This inverse association for PLC is different from those for other cancer types in the same cohort. These results warrant further studies such as using Mendelian randomization to quantify genetic variation in TL with PLC development. Citation Format: Sindhu Karnam, Kathryn Demanelis, Kenneth B. Beckman, Renwei Wang, Jennifer Adams-Haduch, Woon-Puay Koh, Jian-Min Yuan. Shorter leukocyte telomere length and higher risk of primary liver cancer in a prospective cohort study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3461.

oncology
Associations between Longer Leukocyte Telomere Length and Increased Lung Cancer Risk among Never Smokers in Urban China

Jason Y Y Wong,Xiao-Ou Shu,Wei Hu,Batel Blechter,Jianxin Shi,Kevin Wang,Richard Cawthon,Qiuyin Cai,Gong Yang,Mohammad L Rahman,Bu-Tian Ji,Yutang Gao,Wei Zheng,Nathaniel Rothman,Qing Lan

DOI: https://doi.org/10.1158/1055-9965.EPI-23-0881

2023-12-01

Abstract:Background: The complex relationship between measured leukocyte telomere length (LTL), genetically predicted LTL (gTL), and carcinogenesis is exemplified by lung cancer. We previously reported associations between longer pre-diagnostic LTL, gTL, and increased lung cancer risk among European and East Asian populations. However, we had limited statistical power to examine the associations among never smokers by gender and histology. Methods: To investigate further, we conducted nested case-control analyses on an expanded sample of never smokers from the prospective Shanghai Women's Health Studies (798 cases and 792 controls) and Shanghai Men's Health Studies (161 cases and 162 controls). We broke the case-control matching and used multivariable unconditional logistic regression models to estimate the ORs and 95% confidence intervals (CI) of incident lung cancer and adenocarcinoma (LUAD), in relation to LTL measured using quantitative PCR and gTL determined using a polygenic score. In addition, we conducted Mendelian randomization (MR) using MR-PRESSO. Results: We found striking dose-response relationships between longer LTL and gTL, and increased lung cancer risk among never-smoking women (P trendLTL = 4×10-6; P trendgTL = 3×10-4). Similarly, among never-smoking men, longer measured LTL was associated with over triple the risk compared with those with the shortest (OR, 3.48; 95% CI, 1.85-6.57). The overall results were similar for LUAD among women and men. MR analyses supported causal associations with LUAD among women (OR1 SD gTL, 1.19; 95% CI, 1.03-1.37; P = 0.03). Conclusions: Longer pre-diagnostic LTL is associated with increased lung cancer risk among never smokers. Impact: Our findings firmly support the role of longer telomeres in lung carcinogenesis.
Association between telomere length and survival in patients with idiopathic pulmonary fibrosis

jinghong dai,hourong cai,hui li,yi zhuang,haiyan min,yanting wen,jie yang,qian gao,yi shi,long yi

DOI: https://doi.org/10.1111/resp.12566

IF: 6.9

2015-01-01

Respirology

Abstract:Background and objectiveShort telomere is a crucial risk factor for idiopathic pulmonary fibrosis (IPF). However, little is known about the association between baseline telomere length and survival in IPF. We aimed to determine whether telomere length is associated with survival of IPF. MethodsLeukocyte telomere lengths were measured by quantitative polymerase chain reaction in IPF patients at the time of the initial enrolment assessment in Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University. The primary endpoint was the survival of the IPF patients since their initial enrolment assessment. ResultsNinety-four IPF patients were enrolled between 1 January 2012 and 30 June 2014. The mean age-adjusted telomere length of IPF patients (0.850.60) was significantly shorter than age-matched controls (1.150.60, P=0.001). During the follow-up period, 43 IPF patients died. The mean age-adjusted telomere length of the non-survivors (0.610.53) was significantly shorter than that of the survivors (1.03 +/- 0.59, P=0.005). The association between telomere length (hazard ratio (HR) 0.470 (95% confidence interval (CI): 0.25-0. 89); P=0019) and survival in patients with IPF was independent of age, sex, forced vital capacity or diffusing capacity of carbon monoxide. After excluding the six patients with telomerase gene mutations, telomere length (HR 0.46 (95% CI: 0.24-0.88); P=0018) remained an independent predictor of survival time in patients with IPF. ConclusionsShort telomere length is independently associated with worse survival in IPF. Future research should focus on the molecular mechanism underlying the shortening of telomere length in IPF. The mean age-adjusted telomere length of IPF patients was significantly shorter than age-matched controls, so was that of non-survivors of IPF patients versus the survivors. Shorter telomere length is independently associated with worse survival in IPF.
Leukocyte telomere length, cancer incidence and all‐cause mortality among Chinese adults: Singapore Chinese Health Study

Hamed Samavat,Hung N. Luu,Kenneth B. Beckman,Aizhen Jin,Renwei Wang,Woon‐Puay Koh,Jian‐Min Yuan

DOI: https://doi.org/10.1002/ijc.33211

2020-08-05

International Journal of Cancer

Abstract:Telomeres play a key role in chromosomal maintenance and stability. To date, few studies have investigated the association of leukocyte telomere length with risk of cancer incidence and allcause mortality in a large prospective cohort, particularly of the Asian population. Relative telomere lengths in genomic DNA from peripheral blood samples were quantified using a validated quantitative real‐time PCR among 26,540 middle‐aged or older Chinese adults. Hazard ratios (HRs) and 95% confidence intervals (CIs) of cancer and deaths by quintiles of telomere length were calculated using the Cox proportional hazards regression method with adjustment for age, sex, and other potential confounders. After baseline blood collection, 4,353 persons developed cancer and 7,609 died. Participants with the longest decile of telomeres had a 26% (95% CI: 11%–44%) higher risk of total cancer incidence compared to the shortest decile after controlling for age, sex, and other potential founders (Ptrend< 0.0001). In contrast, longer telomeres were associated with lower risk of all‐cause mortality (HR=0.93; 95% CI: 0.84–1.03), non‐cancer death (HR=0.81; 95% CI: 0.71–0.92), specifically, death from chronic obstructive pulmonary disease and pneumonia (HR = 0.79, 95% CI: 0.70–0.89) and digestive diseases (HR = 0.60, 95% CI: 0.42–0.88). Our findings demonstrated that longer telomeres are associated with increased risk of cancer development overall and several common cancer types including breast, rectal, prostate, pancreatic cancer, and lung adenocarcinoma. Our study also confirmed that longer telomeres are associated with a reduced risk of non‐cancer related death.This article is protected by copyright. All rights reserved.
Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Ping Yuan,Sha Huang,Fei-Chao Bao,Jin-Lin Cao,Hong-Xu Sheng,Liang Shi,Wang Lv,Jian Hu

DOI: https://doi.org/10.1016/j.ejca.2019.06.024

IF: 10.002

2019-01-01

European Journal of Cancer

Abstract:Background: The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation. Methods: The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients' clinical outcomes with a median follow-up of 57 months (2-99 months). Results: The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p < 0.001 for both) and shorter RTL (versus C/C and versus T/T; p = 0.039 and 0.023) in patients without EGFR mutation. Such difference was not observed in their counterparts harbouring EGFR mutation. When considering the cohort as a whole, T/C allele was significantly associated with shortest overall survival compared with T/T or C/C allele (mean: 61.8, 80.9 and 88.7 months, p(log-rank) < 0.001) and disease-free survival (mean: 78.3, 87.9 and 91.5 months, p(log-rank) = 0.019). Stratification analyses showed that the negative prognostic effect of T/C on OS was constrained in patients without EGFR mutation. Conclusion: Our study revealed significant associations of a common SNP within TERT promoter region on telomere parameters and survival in NSCLC patients without EGFR mutation. The result may help providing instruction for therapeutic interventions targeting telomerase and evidence for investigation of TERT-EGFR interacting mechanism in telomere biology. (C) 2019 Elsevier Ltd. All rights reserved.
[Repeated detection of increased transaminases].

R. Baumgarten,R. Nilius

1991-04-10

Abstract:
17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Lijiao Xiong,Guangyan Yang,Tianting Guo,Zhaohao Zeng,Tingfeng Liao,Yanchun Li,Ying Li,Fujuan Chen,Shu Yang,Lin Kang,Zhen Liang

DOI: https://doi.org/10.1186/s13098-023-01206-7

2023-01-01

Diabetology & Metabolic Syndrome

Abstract:Abstract Background The relationship between leukocyte telomere length (LTL) and mortality risk in individuals with metabolic syndrome (MetS) remains poorly understood. This study aimed to investigate the association between telomere length and long-term all-cause mortality, and cardiovascular disease (CVD) mortality, in individuals with MetS in the United States. Methods A total of 1980 participants with MetS aged 18 years or older from the National Health and Nutrition Examination Survey (NHANES) prospective cohort study (1999–2002) were included in this cohort study. Medical records review was used to identify the cause of deaths as of December 2018. We employed Kaplan-Meier curves, fitted curves, and Cox proportional hazards regression models to estimate hazard ratios (HRs) for all-cause and CVD mortality, stratified by tertiles of LTL. Results Over a median follow-up of 17.75 years of participants with metabolic syndrome, 819 deaths occurred, including 231 cardiovascular deaths. After adjusting for multiple covariates, participants with shorter telomere length had a significantly higher risk of all-cause mortality (HR, 1.33; 95% CI, 1.11–1.6) and CVD mortality (HR, 1.36; 95% CI, 0.96–1.93) compared with those in the highest tertile of telomere length. All-cause mortality (P < 0.001) and cardiovascular disease mortality (P = 0.028) followed a similar pattern across tertiles of telomere length. Conclusion In individuals with MetS, shorter telomere length is associated with increased risks of death from cardiovascular disease and all causes. The underlying mechanisms and clinical implications of these findings require additional investigation.
Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms

Florence Friggi-Grelin,Magali Iché,S. Birman

DOI: https://doi.org/10.1002/gene.10178

2003-03-01

genesis

Abstract:Summary: Drosophila tyrosine hydroxylase (DTH) is a key enzyme in dopamine (DA) biosynthesis, which is expressed in neural and hypodermal DA‐synthesizing cells. We previously reported that two DTH isoforms are produced in flies through tissue‐specific alternative splicing that show distinct regulatory properties. We have now selectively expressed each DTH isoform in vivo in a pale (ple, i.e., DTH‐deficient) mutant background. We show that the embryonic lethality of ple can be rescued by expression of the hypodermal, but not the neural, DTH isoform in all DA cells, indicating that the hypoderm‐ isoform is absolutely required for cuticle biosynthesis and survival in Drosophila. In addition, we report new observations on the consequences of DTH overexpression in the CNS and hypoderm. Our results provide evidence that tissue‐specific alternative splicing of the DTH gene is a vital process in Drosophila development. genesis 35:175–184, 2003. © 2003 Wiley‐Liss, Inc.
Telomerase Gene Mutations and Telomere Length Shortening in Patients with Idiopathic Pulmonary Fibrosis in a Chinese Population.

Jinghong Dai,Hourong Cai,Yi Zhuang,Yongzheng Wu,Haiyan Min,Jinheng Li,Yi Shi,Qian Gao,Long Yi

DOI: https://doi.org/10.1111/resp.12422

IF: 6.9

2014-01-01

Respirology

Abstract:Background and objectiveIdiopathic pulmonary fibrosis (IPF) is an age-related disease and the most common manifestation of telomere-mediated disorders.MethodsWe collected detailed medical histories and DNA samples from 100 IPF patients seen at Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University. All patients had sporadic IPF, with no family history reported. We screened all patients for telomerase reverse transcriptase (TERT) and telomerase RNA component (TERC) variants, and measured their telomere lengths in lymphocytes.ResultsSix novel telomerase gene mutations were identified in six IPF patients enrolled in the studies. They were two heterozygous mutations in TERC (257 G>A and 108 C>T) and four in TERT (R622H, T644M, V777L and F1032I). IPF patients with TERT/TERC mutations had significant thrombocytopaenia (160.16728.089x10(9)) compared with the non-mutation groups (191.01871.187x10(9), P=0.047). All IPF patients with TERT/TERC mutations had shortened telomeres (0.656 +/- 0.125) compared with the patients lacking TERT/TERC mutations (1.080 +/- 0.6819, P=0.0184). IPF patients lacking TERT or TERC mutations (1.080 +/- 0.6819) had significantly shorter telomeres compared with age-matched healthy controls (1.244 +/- 0.5890, P=0.0355).ConclusionsSix novel mutations in the telomerase genes were identified for the first time in individuals diagnosed with sporadic IPF in a Chinese Han population. Shorter telomeres and mild thrombocytopaenia could be clues to association with telomerase gene mutation and sporadic IPF.Six novel mutations in the telomerase genes with shorter telomeres were identified for the first time in sporadic idiopathic pulmonary fibrosis (IPF) in a Chinese Han population. Shorter telomeres and mild thrombocytopaenia could be clues to association with telomerase gene mutation and sporadic IPF.
Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

Zhang,D.,Adegunsoye,A.,Oldham,J. M.,Wolters,P. J.,Garcia,C. K.,Newton,C. A.

DOI: https://doi.org/10.1183/13993003.02146-2023

IF: 24.3

2024-01-18

European Respiratory Journal

Abstract:Extract We thank J.A. Mackintosh and D.C. Chambers for their thoughtful discussions following our work detailing the pharmacogenetic interaction between telomere shortening and immunosuppression leading to harm in patients with non-idiopathic pulmonary fibrosis interstitial lung disease (ILD) patients [1]. Our findings suggest that shared genetic vulnerability to pulmonary fibrosis from telomere attrition may also inform a personalised approach to treatment. As J.A. Mackintosh and D.C. Chambers astutely point out, this study presumed an accurate ILD diagnostic categorisation through multidisciplinary discussions. Limitations notwithstanding, this classification schema remains the current standard for ILD diagnosis and treatment. While we agree with the prospect of genomics-informed ILD taxonomy as a successor to a purely phenotype-driven classification, we believe that the transition must be pursued carefully and systematically. As such, our findings of genomic marker associations with outcomes across ILD diagnostic subtypes is a rational next step towards incorporating genetic information into ILD decision-making.

respiratory system
Abstract 620: Associations of Genomic Alteration, Tumor Mutational Burden with PD-L1 Expression and Response to Immune Checkpoint Inhibitors in Chinese Lung Patients

Jing Hu,Bixun Li,Bing Zou,Senming Wang,Ye Qiu,Maolin Yan,Zhiming Zeng,Han Yang,Yan Guan,Lei Zhang,Wei Chen,Yuan Zhang,Lei Mei,Xiaowei Dong,Ming Yao,Kai Wang

DOI: https://doi.org/10.1158/1538-7445.am2018-620

IF: 11.2

2018-01-01

Cancer Research

Abstract:Background: For advanced or metastatic lung cancer patients (pts) in the absence of actionable genetic alterations, whose disease progressed after chemotherapy, the effective treatment options are limited. Recently, PD-1/PD-L1 inhibitors have demonstrated improved survival in advanced lung cancer. However, sufficient evidence is still lacking in Chinese lung cancer pts. Methods: Twenty lung cancer pts including 12 adenocarcinomas and 5 squamous cell carcinomas who received anti-PD-1/PD-L1 treatments as first- to fourth-line therapy were retrospectively reviewed. The majority of the pts were stage IV (17 pts). PD-L1 expression was analyzed by immunohistochemical staining. Genomic alterations were detected by using a next-generation sequencing (NGS) assay targeting 450 cancer genes. Tumor mutational burden (TMB) and microsatellite instability (MSI) status were acquired by NGS algorithm. Results: The median age of the 20 pts was 57 years (range: 36-69) and male vs. female was 3. The median time from date of diagnosis to the date of the first anti-PD-1/PD-L1 treatment was 9.5 months (range: 1-69 months). The overall response rate was 89%, including 8 partial response (PR), 9 stable disease (SD) and 2 progressive disease (PD), and the median PFS (mPFS) was not reached (NR) (range: 0.5-NR). Seven pts had one or more targetable oncogenic mutations including EGFR L858R (2) and amplification, PIK3CA (1), BRAF, ERBB2, PTEN, and ROS1 fusion. The median TMB value of the 20 pts was 11 muts/Mb (range: 2.4-38 muts/Mb). 45% of the pts had TMB greater than 20 muts/Mb, and 60% had TMB greater than 10 muts/Mb. Among the 9 pts who had the TMB greater than 20 muts/Mb, 5 pts achieved PR, 4 achieved SD, mPFS was not reached. Also, 5 pts including 2 PR and 3 SD were identified as MSI-high. In the PD-L1 positive subgroup (N=11), 5 pts achieved PR, 5 achieved SD and 1 had a PD. Furthermore, we found 5 pts with NFE2L2 mutations including 2 adenocarcinomas and 3 squamous cell carcinomas, associated with high TMB values (>20 muts/Mb) and PD-L1 positivity; all 5 pts had response to anti-PD-1/PD-L1 treatment, which include 3 PR and 2 SD with mPFS not reached (range: 6-NR). Conclusion: Our preliminary results based on a small number of pts showed a significant association between high TMB values and response of immune checkpoint inhibitors in Chinese lung cancer pts, and a strong correlation between high TMB values and high PD-L1 expression. We also reported that NFE2L2 mutation was tightly associated with high TMB value (P=0.011) and PD-L1 positivity (P=0.038), which may serve as a new predictive biomarker for advanced or metastatic lung cancer pts receiving anti-PD-1/PD-L1 treatments. Further larger cohort study is warranted. Citation Format: Jing Hu, Bixun Li, Bing Zou, Senming Wang, Ye Qiu, Maolin Yan, Zhiming Zeng, Han Yang, Yan Guan, Lei Zhang, Wei Chen, Yuan Zhang, Lei Mei, Xiaowei Dong, Ming Yao, Kai Wang. Associations of genomic alteration, tumor mutational burden with PD-L1 expression and response to immune checkpoint inhibitors in Chinese lung patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 620.
Genetic Variants Associated with Longer Telomere Length Are Associated with Increased Lung Cancer Risk among Never-Smoking Women in Asia: a Report from the Female Lung Cancer Consortium in Asia.

Mitchell J. Machiela,Chao Agnes Hsiung,Xiao-Ou Shu,Wei Jie Seow,Zhaoming Wang,Keitaro Matsuo,Yun-Chul Hong,Adeline Seow,Chen Wu,H. Dean Hosgood,Kexin Chen,Jiu-Cun Wang,Wanqing Wen,Richard Cawthon,Nilanjan Chatterjee,Wei Hu,Neil E. Caporaso,Jae Yong Park,Chien-Jen Chen,Yeul Hong Kim,Young Tae Kim,Maria Teresa Landi,Hongbing Shen,Charles Lawrence,Laurie Burdett,Meredith Yeager,I-Shou Chang,Tetsuya Mitsudomi,Hee Nam Kim,Gee-Chen Chang,Bryan A. Bassig,Margaret Tucker,Fusheng Wei,Zhihua Yin,She-Juan An,Biyun Qian,Victor Ho Fun Lee,Daru Lu,Jianjun Liu,Hyo-Sung Jeon,Chin-Fu Hsiao,Jae Sook Sung,Jin Hee Kim,Yu-Tang Gao,Ying-Huang Tsai,Yoo Jin Jung,Huan Guo,Zhibin Hu,Amy Hutchinson,Wen-Chang Wang,Robert J. Klein,Charles C. Chung,In-Jae Oh,Kuan-Yu Chen,Sonja I. Berndt,Wei Wu,Jiang Chang,Xu-Chao Zhang,Ming-Shyan Huang,Hong Zheng,Junwen Wang,Xueying Zhao,Yuqing Li,Jin Eun Choi,Wu-Chou Su,Kyong Hwa Park,Sook Whan Sung,Yuh-Min Chen,Li Liu,Chang Hyun Kang,Lingmin Hu,Chung-Hsing Chen,William Pao,Young-Chul Kim,Tsung-Ying Yang,Jun Xu,Peng Guan,Wen Tan,Jian Su,Chih-Liang Wang,Haixin Li,Alan Dart Loon Sihoe,Zhenhong Zhao,Ying Chen,Yi Young Choi,Jen-Yu Hung,Jun Suk Kim,Ho-Il Yoon,Qiuyin Cai,Chien-Chung Lin,In Kyu Park,Ping Xu,Jing Dong,Christopher Kim,Qincheng He,Perng,Takashi Kohno,Sun-Seog Kweon,Chih-Yi Chen,Roel C. H. Vermeulen,Junjie Wu,Wei-Yen Lim,Kun-Chieh Chen,Wong-Ho Chow,Bu-Tian Ji,John K. C. Chan,Minjie Chu,Yao-Jen Li,Jun Yokota,Jihua Li,Hongyan Chen,Yong-Bing Xiang,Chong-Jen Yu,Hideo Kunitoh,Guoping Wu,Li Jin,Yen-Li Lo,Kouya Shiraishi,Ying-Hsiang Chen,Hsien-Chih Lin,Tangchun Wu,Maria Pik Wong,Yi-Long Wu,Pan-Chyr Yang,Baosen Zhou,Min-Ho Shin,Joseph F. Fraumeni,Wei Zheng,Dongxin Lin,Stephen J. Chanock,Nathaniel Rothman,Qing Lan

DOI: https://doi.org/10.1002/ijc.29393

IF: 11.2

2015-01-01

Cancer Research

Abstract:Recent evidence from several relatively small nested case‐control studies in prospective cohorts shows an association between longer telomere length measured phenotypically in peripheral white blood cell (WBC) DNA and increased lung cancer risk. We sought to further explore this relationship by examining a panel of seven telomere‐length associated genetic variants in a large study of 5,457 never‐smoking female Asian lung cancer cases and 4,493 never‐smoking female Asian controls using data from a previously reported genome‐wide association study. Using a group of 1,536 individuals with phenotypically measured telomere length in WBCs in the prospective Shanghai Women's Health study, we demonstrated the utility of a genetic risk score (GRS) of seven telomere‐length associated variants to predict telomere length in an Asian population. We then found that GRSs used as instrumental variables to predict longer telomere length were associated with increased lung cancer risk (OR = 1.51 (95% CI = 1.34–1.69) for upper vs. lower quartile of the weighted GRS, p value = 4.54 × 10−14) even after removing rs2736100 (p value = 4.81 × 10−3), a SNP in the TERT locus robustly associated with lung cancer risk in prior association studies. Stratified analyses suggested the effect of the telomere‐associated GRS is strongest among younger individuals. We found no difference in GRS effect between adenocarcinoma and squamous cell subtypes. Our results indicate that a genetic background that favors longer telomere length may increase lung cancer risk, which is consistent with earlier prospective studies relating longer telomere length with increased lung cancer risk.
Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study

Meiling Liu,Ping Luo,Lihua Liu,Xianping Wei,Xue Bai,Jicui Li,Linlin Wu,Manyu Luo

DOI: https://doi.org/10.3389/fgene.2023.1129247

IF: 3.7

2023-04-18

Frontiers in Genetics

Abstract:Objective: To elucidate the potential causality of leukocyte telomere length (LTL) with immune-mediated inflammatory diseases (IMIDs), we conducted a Mendelian randomization (MR) study. Methods: The genetically predicted causation between LTL and IMIDs was evaluated using a two-sample MR method. We analyzed 16 major IMIDs, which included systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), ulcerative colitis (UC), Crohn's disease (CD), ankylosing spondylitis (AS), sicca syndrome (SS), rheumatoid arthritis (RA), type 1 diabetes (T1D), primary sclerosing cholangitis (PSC), idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD), sarcoidosis, hypothyroidism, hyperthyroidism, psoriasis, and childhood asthma. The random-effects inverse-variance weighted (IVW) method was performed as the main analytical approach in MR. Various sensitivity analyses, including MR-Egger, MR robust adjusted profile score (MR-RAPS), weighted median, MR pleiotropy residual sum and outlier (MR-PRESSO) methods, weighted mode, radial plot, and radial regression, were used to guarantee the robustness of the results and detect horizontal pleiotropy. Cochran's Q value was calculated to check for heterogeneity, and the MR Steiger approach was used to test the causal direction. Results: The MR results indicated significant inverse associations of LTL with risks of psoriasis (OR: 0.77, 95% CI: 0.66–0.89, and p = 3.66 × 10 −4 ), SS (OR: 0.75, CI: 0.58–0.98, and p = 0.03), RA (OR: 0.77, 95% CI: 0.68–0.88, and p = 9.85 × 10 −5 ), hypothyroidism (OR: 0.84, 95% CI: 0.78–0.91, and p = 7,08 × 10 −6 ), hyperthyroidism (OR: 0.60, 95% CI: 0.44–0.83, and p = 1.90 × 10 −3 ), sarcoidosis (OR: 0.67, 95% CI: 0.54–0.83, and p = 2.60 × 10 −4 ), and IPF (OR: 0.41, 95% CI: 0.29–0.58, and p = 4.11 × 10 −7 ) in the FinnGen study. We observed that longer LTL was associated with an increased risk of AS susceptibility (OR: 1.51, 95% CI: 1.18–1.94, and p = 9.66 × 10 −4 ). The results of the IVW method showed no causal relationship between TL and SLE (OR: 0.92, 95% CI: 0.62–1.38, and p = 0.69) in the FinnGen study; however, a significantly positive correlation was shown between LTL and SLE in another larger GWAS (OR: 1.87, 95% CI: 1.37–2.54, and p = 8.01 × 10 −5 ). Conclusion: Our findings reveal that abnormal LTL has the potential to increase the risk of IMIDs. Therefore, it could be treated as a predictor and may provide new potential treatment targets for IMIDs. However, the change of LTL may not be the direct cause of IMIDs. Further studies should aim at the pathogenic mechanism or potential protective effects of LTL in IMIDs.

genetics & heredity
Association of Telomere Length with Risk of Lung Cancer: A Large Prospective Cohort Study from the UK Biobank

Duoduo Han,Yiqun Zhu,Abira A. Choudhry,Jun Cheng,Huaying Liang,Fengyu Lin,Qinyu Chang,Hong Liu,Pinhua Pan,Yan Zhang

DOI: https://doi.org/10.1016/j.lungcan.2023.107358

IF: 6.081

2023-09-04

Lung Cancer

Abstract:Objectives Leukocyte telomere length (LTL) is associated with a wide variety of diseases, including cancer. However, findings regarding the association between LTL and the risk for lung cancer have been inconclusive and inconsistent across previous observational studies. Methods This prospective cohort study included data from 425,146 participants 37–73 years of age housed in the UK Biobank. Quantitative polymerase chain reaction (qPCR) was used to measure LTL in baseline DNA samples. A multivariate Cox proportional hazards model was used to evaluate the relationship between LTL and the risk for lung cancer. Results An increase in LTL per interquartile range (IQR) was associated with a 9% increase in the risk for lung cancer (hazard ratio [HR] 1.09 [95% confidence interval (CI) 1.03–1.16]). Participants in the highest LTL quintile exhibited an approximately 25% elevated risk for developing lung cancer (HR 1.25 [95% CI 1.09–1.45]) compared with those in the lowest quintile. The relationship between per IQR increase in LTL and elevated risk for lung cancer was greater in the histological subtype of adenocarcinoma (HR 1.30 [95% CI 1.18–1.43]), female sex (HR 1.16 [95% CI 1.06–1.26]), non-smokers (HR 1.45 [95% CI 1.23–1.71]), and individuals with high genetic risk for lung cancer (HR 1.18 [95% CI 1.03–1.34]), respectively. Surprisingly, a per IQR increase in LTL was associated with increased risks for both lung adenocarcinoma (HR 1.56 [95% CI 1.24–1.96]) and squamous cell carcinoma (HR 2.01 [95% CI 1.13–3.56]) in never smokers. Conclusions Longer LTL was associated with an elevated risk for lung cancer, particularly for adenocarcinoma and squamous cell carcinoma in never smokers. The results suggest the potential of telomeres as non-invasive biomarkers for the early screening of lung cancer, particularly in non-smokers, who are typically overlooked.

oncology,respiratory system
[Technic of dosimetry in interstitial curietherapy by unidirectional tomography].

B. Pierquin,H. Nahum,D. Chassagne

Abstract:
Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Jonathan K. Alder,Julian J.-L. Chen,Lisa Lancaster,Sonye Danoff,Shu-chih Su,Joy D. Cogan,Irma Vulto,Mingyi Xie,Xiaodong Qi,Rubin M. Tuder,John A. Phillips,Peter M. Lansdorp,James E. Loyd,Mary Y. Armanios

DOI: https://doi.org/10.1073/pnas.0804280105

IF: 11.1

2008-09-02

Proceedings of the National Academy of Sciences

Abstract:Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Linda Kachuri,Jens Helby,Stig Egil Bojesen,David C Christiani,Li Su,Xifeng Wu,Adonina Tardón,Guillermo Fernández-Tardón,John K Field,Michael P Davies,Chu Chen,Gary E Goodman,Frances A Shepherd,Natasha B Leighl,Ming S Tsao,Yonathan Brhane,M Catherine Brown,Kevin Boyd,Daniel Shepshelovich,Lei Sun,Christopher I Amos,Geoffrey Liu,Rayjean J Hung

DOI: https://doi.org/10.1158/1055-9965.EPI-18-1215

2019-01-01

Cancer Epidemiology Biomarkers & Prevention

Abstract:Background: Lung cancer remains the leading cause of cancer mortality with relatively few prognostic biomarkers. We investigated associations with overall survival for telomere length (TL) and genetic variation in chromosome 5p15.33, an established telomere maintenance locus. Methods: Leukocyte TL was measured after diagnosis in 807 patients with non-small cell lung cancer (NSCLC) from the Princess Margaret Cancer Center in Toronto and assessed prospectively in 767 NSCLC cases from the Copenhagen City Heart Study and the Copenhagen General Population Study. Associations with all-cause mortality were tested for 723 variants in 5p15.33, genotyped in 4,672 NSCLC cases. Results: Short telomeres (<= 10th percentile) were associated with poor prognosis for adenocarcinoma in both populations: TL measured 6 months after diagnosis [HR = 1.65; 95% confidence intervals (CI), 1.04-2.64] and for those diagnosed within 5 years after blood sampling (HR = 2.42; 95% CI, 1.37-4.28). Short TL was associated with mortality in never smokers with NSCLC (HR = 10.29; 95% CI, 1.86-56.86) and adenocarcinoma (HR = 11.31; 95% CI, 1.96-65.24). Analyses in 5p15.33 identified statistically significant prognostic associations for rs56266421-G in LPCAT1 (HR = 1.86; 95% CI, 1.38-2.52; P = 4.5 x 10(-5)) in stage I-IIIA NSCLC, and for the SLC6A3 gene with OS in females with NSCLC (P = 1.6 x 10(-3)). Conclusions: Our findings support the potential clinical utility of TL, particularly for adenocarcinoma patients, while associations in chromosome 5p15.33 warrant further exploration. Impact: This is the largest lung cancer study of leukocyte TL and OS, and the first to examine the impact of the timing of TL measurement. Our findings suggest that extremely short telomeres are indicative of poor prognosis in NSCLC.

Mitral insufficiency and pulmonary hypertension accompanying patent ductus arteriosus; report of three cases.

Low frequency variants associated with leukocyte telomere length in the Singapore Chinese population

Clinical Impact of Telomere Length Testing for Interstitial Lung Disease

Recent intellectual property law changes and their impact on drug discovery.

Abstract 3461: Shorter leukocyte telomere length and higher risk of primary liver cancer in a prospective cohort study

Associations between Longer Leukocyte Telomere Length and Increased Lung Cancer Risk among Never Smokers in Urban China

Association between telomere length and survival in patients with idiopathic pulmonary fibrosis

Leukocyte telomere length, cancer incidence and all‐cause mortality among Chinese adults: Singapore Chinese Health Study

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

[Repeated detection of increased transaminases].

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms

Telomerase Gene Mutations and Telomere Length Shortening in Patients with Idiopathic Pulmonary Fibrosis in a Chinese Population.

Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

Abstract 620: Associations of Genomic Alteration, Tumor Mutational Burden with PD-L1 Expression and Response to Immune Checkpoint Inhibitors in Chinese Lung Patients

Genetic Variants Associated with Longer Telomere Length Are Associated with Increased Lung Cancer Risk among Never-Smoking Women in Asia: a Report from the Female Lung Cancer Consortium in Asia.

Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study

Association of Telomere Length with Risk of Lung Cancer: A Large Prospective Cohort Study from the UK Biobank

[Technic of dosimetry in interstitial curietherapy by unidirectional tomography].

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.